Garnizole Cream contains Luliconazole 1.0% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of various superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and fungal cell death. Garnizole Cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis, providing effective relief from symptoms including itching, redness, scaling, and inflammation. The cream formulation allows for easy application and rapid absorption, ensuring targeted delivery to the affected area. Clinical studies have demonstrated that Luliconazole 1.0% cream offers superior efficacy with a shorter treatment duration compared to other antifungal agents. It is generally well tolerated, with minimal adverse effects reported, such as mild local irritation or burning sensation at the application site. Garnizole Cream should be applied once daily to the affected area and surrounding skin after cleansing, continuing treatment for the full prescribed duration to prevent recurrence. Patients are advised to avoid contact with eyes and mucous membranes and to consult a healthcare professional if symptoms persist or worsen.